title: Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering.
authors.affiliation: Molecular Targeting and Polymer Toxicology Group, School of Pharmacy, University of Brighton, Brighton BN2 4GJ, U.K.
authors.forename: Islam
authors.initials: I
authors.lastname: Hamad
authors.forename: Othman
authors.initials: O
authors.lastname: Al-Hanbali
authors.forename: A Christy
authors.initials: AC
authors.lastname: Hunter
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Rutt
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Andresen
authors.forename: S Moein
authors.initials: SM
authors.lastname: Moghimi
mesh_terms: D000327:Adsorption; D000818:Animals; D003167:Complement Activation / Q000187:drug effects*; D004738:Engineering / Q000379:methods*; D005029:Ethylenediamines / Q000737:chemistry; D006801:Humans; D037102:Lectins / Q000378:metabolism; D008297:Male; D054118:Nanospheres / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry* / Q000493:pharmacokinetics / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D044967:Serum / Q000187:drug effects / Q000276:immunology*; D013329:Structure-Activity Relationship
chemical_list: D005029:Ethylenediamines; D037102:Lectins; C012571:tetronic 701; D011092:Polyethylene Glycols